Please provide your email address to receive an email when new articles are posted on . Fecal microbiota therapeutics are “incredibly effective” for the treatment of Clostridiodes difficile infection.
Early-onset neonatal bacterial infection is a major cause of morbidity and mortality, especially in preterm newborns. It is most often caused by ascending infection via the maternal genital tract.
The interplay between host immunity, the microbiota, and cancer is a rapidly evolving area of immuno-oncology. An increasing body of evidence highlights the ...
The gut microbiota might perhaps one day become a routine tool for the early diagnosis of many diseases and to guide treatment, but at present there is a lack of solid scientific evidence to support ...
GIJÓN, ASTURIAS, Spain--(BUSINESS WIRE)--Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, ...
As the name suggests, a faecal microbiota transplant introduces gut microbes from a carefully screened healthy donor’s stool ...
Tokyo, Japan – October 8, 2025 – The International Society of Microbiota (ISM) and RIKEN will host the prestigious Innovation Awards Gala during the First Conjoint Meeting ISM × RIKEN, taking place at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results